SELLAS Life Sciences 10K 2011 Annual report | SLS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accuracy, Agilent, AkPharma, Anderson, andParsoon, annum, Antonio, Aria, Arrowhead, Astor, ASU, Australian, Bay, bearing, bio, biopharma, blanket, blockbuster, bridge, budget, Canadian, cancelled, Cantor, Capstone, captionedCranshire, captionedHudson, captionedTenor, Chin, China, Chinese, cited, civ, CoDa, collabo, collateral, colorectal, combi, comparison, Complaint, Computershare, concert, concurrence, concurrently, dation, David, decision, declaratory, default, depositor, Derma, DFS, District, Document, Dong, earnout, Eastern, endometrial, entirety, error, ESPP, Europe, evergreen, Excaliard, exceeded, expressly, Eyegene, fault, FBP, feature, FINRA, FirstString, Fitzgerald, Flow, folate, fraud, GALE, galena, Garnet, gastric, Gateway, Genzyme, gynecological, Halscion, hand, Healthpoint, HJF, homology, Hudson, imminent, incidental, indefinite, ing, injunctive, Instance, intradermal, invasive, Japan, Japanese, journal, JPO, Kissei, Korea, Kwang, Kwangdong, Lake, lattice, lawyer, Lee, lend, Leukemia, lien, liqui, LO, LP, macro, maker, malignancy, MDACC, meaningful, Memorial, Meridian, Merz, methodology, Mexico, microarray, midst, Military, missing, moot, mount, multicenter, multiyear, Nanotechnology, NCCN, Network, newly, Nisi, occupied, ofASC, OfferingSM, Oregon, ori, Oswego, OTC, Parsoon, persuasive, Pharmaxon, pivotal, placebo, pledged, Promedior, promissory, proteosomal, purport, Quantitative, randomized, ratio, rationale, rative, receptor, reclassification, reconciliation, reevaluated, regimen, relief, remeasured, remission, renal, Renovo, repay, repayment, resolved, restated, retrospectively, reversal, revert, Richard, routine, RTW, Rudolph, San, Scheinberg, Schema, South, Southern, Specimen, spin, stale, step, Subscription, sued, supplement, supplier, Tang, Taxonomy, territorial, tranche, Turner, unaudited, undertook, undiscounted, unissued, view, Vincent, website, wholly, XBRL, York

Removed: acquirer, ActRule, add, added, addressed, advice, Albert, allocated, assist, attack, aware, bodily, borne, bound, brain, Calando, caption, Carnegie, CEO, characterized, cholesterol, collaborating, collaboration, comprising, consult, consultant, conventional, convey, create, created, creating, CYTR, Czech, decreased, degrade, degraded, depicted, desire, disaggregated, disclaim, discrete, driven, duplex, employ, encapsulated, encompassing, environment, expectation, expend, explicitly, feasible, FileNo, finite, founding, friendly, GeRP, Global, Glucan, Gregory, groundbreaking, half, Hannon, harm, hereof, Hospital, identifying, implementation, importantly, incurrence, inflammatory, ingredient, input, intending, IP, journalScience, knowledge, Lasker, left, Likewise, lived, mandated, manifest, measurable, Michael, microRNA, middle, miRNA, modulate, Nassim, novelty, ofDrug, onForm, operated, optimizing, overhang, owner, paired, pairing, participate, partner, range, rapidly, recipient, regulating, relevance, reliably, rental, rxRNAtm, satisfying, SEDA, seminal, sensitivity, serve, siStable, spent, stabilization, stabilized, Standby, successor, susceptible, terminable, thought, timeline, Todayby, TriLink, uncured, Usman, varied, Victor, Washington, YA, yearly


Name	Ownership Percentage			Jurisdiction of Organization
Apthera, Inc.		100	%		Delaware

RXi Pharmaceuticals Corporation		100	%		Delaware

SELLAS Life Sciences (SLS) 10-K2011 FY Annual report

Content analysis